Jong Tae Lim

Dr. Jong Tae Lim

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2025 in Plant Cell, Tissue and Organ Culture (PCTOC)
Verified
Journal Article
Open access
PDF file
FMFeruza MUSTAFINA
Feruza MUSTAFINA
DJDilafruz Ne'matilla qizi Jamalova
Dilafruz Ne'matilla qizi Jamalova
AZAmir Reza Zarekarizi
Amir Reza Zarekarizi
HJHanifabonu Kobul Kizi Juraeva
Hanifabonu Kobul Kizi Juraeva
AKAbbos Tulkin Ogli Khazratov
Abbos Tulkin Ogli Khazratov
JLJong Tae Lim
Jong Tae Lim
This study investigated the antioxidant potential of callus cultures derived from the endangered medicinal plant Ferula tadshikorum Pimenov (Apiaceae Lindl.), an endemic species in Central Asia. The plant’s long life cycle and overharvesting threaten its survival, necessitating the development of in vitro microclonal propagation protocols as a sustainable solution for bioactive compound production. Two propagation methods, indirect organogenesis and indirect somatic embryogenesis, were optimized using zygotic embryos as explants. Callus cultures at early stages, cultivated on Murashige and Skoog medium supplemented with 0.5 mg/l 2,4-dichlorophenoxyacetic acid, demonstrated antioxidant activity, with 2,2-diphenyl-1-picrylhydrazyl (DPPH) half-maximal inhibitory concentration (IC₅₀) values as low as 15.41 µg/mL, comparable to ascorbic acid (15.17 µg/mL), while the radical-scavenging activity in the 2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) assay was even higher. Optimal bioactivity and extract yields were achieved on a Murashige and Skoog medium supplemented with 2.4-dichlorophenoxyacetic acid (0.5 mg/l) and Kinetin or Thidiazuron. Statistical analysis confirmed the influence of hormonal treatments on antioxidant properties. These findings highlight the dual potential of in vitro propagation for conserving F. tadshikorum and providing a sustainable source of bioactive compounds with significant antioxidant properties, supporting pharmaceutical applications. However, challenges in translating these findings into large-scale production or commercial applications must be addressed, including the optimization of protocols for industrial scalability and cost-effectiveness.